International Journal of Infectious Diseases
Volume 14, Issue 8 , Pages e717-e722 , August 2010

Previous treatment in predicting drug-resistant tuberculosis in an area bordering East London, UK

  • Mark Melzer

      Affiliations

    • Department of Microbiology, Queen's Hospital, Barking, Havering and Redbridge Trust, Romford, Essex RM7 OAG, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 0 845 130 4204x3756/6251; fax: +44 0 20 8970 5784.
    • ,
  • Nidhi Gupta

      Affiliations

    • Department of Respiratory Medicine, Queen's Hospital, Romford, Essex, UK
    • ,
  • Irene Petersen

      Affiliations

    • Department of Primary Care and Population Health, University College London Medical School, London, UK
    • ,
  • Sue Cook

      Affiliations

    • Department of Respiratory Medicine, King George Hospital, Goodmayes, Essex, UK
    • ,
  • Bridget Hall

      Affiliations

    • Department of Respiratory Medicine, Queen's Hospital, Romford, Essex, UK

Received 2 June 2009 ,Revised 8 January 2010 ,Accepted 9 February 2010.

References 

  1. Donaldson L. Stopping tuberculosis in England. An action plan from the Chief Medical Officer. London: Department of Health; October 2004. Available at: http://www.dh.gov.uk. (accessed on 10/01/2010).
  2. Kruijshaar ME, Watson JM, Drobniewski F, Anderson C, Brown TJ, Magee JG. Increasing antituberculosis drug resistance in the United Kingdom: analysis of national surveillance data. BMJ. 2008;336:1231–1234
  3. Anderson C, Moore J, Kruijshaar M, Abubakar I. Tuberculosis in the UK. Annual report on tuberculosis surveillance in the UK 2008. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1224268885463. (accessed on 31/5/2010).
  4. Breathnach AS, de Ruiter A, Holdsworth GM, Bateman NT, O'Sullivan DG, Rees PJ. An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J Hosp Infect. 1998;39:111–117
  5. Ormerod P Chair of Joint Tuberculosis Committee of British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax. 1998;53:536–548
  6. Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis. Lancet. 1993;341:647–650
  7. Melzer M, Brown TJ, French GL, Dickens A, McHugh TD, Bagg LR. Molecular analysis of drug resistant TB. Thorax. 2002;57:562–563
  8. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: National Institute for Health and Clinical Excellence; 2006. Available at: http://www.nice.org.uk/CG033. (accessed on 10/01/2010).
  9. Health Protection Agency, 2008. Available at: http://www.hpa.org.uk (accessed on 10/01/2010).
  10. Centers for Disease Control and Prevention (CDC). Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs—worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006; 55:301–5.
  11. Zignol M, Hosseini MS, Wright A, Weezenbeck CL, Nunn P, Watt CJ. Global incidence of multidrug-resistant tuberculosis. J Infect Dis. 2006;194:479–485
  12. Falzon D, Infuso A, Ait-Belghiti F. In the European Union, TB patients from former Soviet countries have a high risk of multidrug resistance. Int J Tuberc Lung Dis. 2006;10:954–958
  13. Wright A, Zignol M, Van Deun A, Falzon D, Gerdes SR, Feldman K. Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet. 2009;373:1861–1873
  14. Collins CH, Grange JM, Yates MD. Tuberculosis bacteriology: organization and practice. Oxford, UK: Butterworth-Heinemann; 1997;
  15. Lietooghe R, Michiels N, Habib S, Moran MB, Muynck A. Perception and social consequences of tuberculosis, a focus group study of tuberculosis patients in Sialkot, Pakistan. Soc Sci Med. 1995;41:1685–1692
  16. al Jarad N, Parastatides S, Paul EA, Sheldon CD, Gaya H, Rudd RM. Characteristics of patients with drug resistant and drug sensitive tuberculosis in East London between 1984 and 1992. Thorax. 1994;49:808–810
  17. Djuretic T, Herbert J, Drobniewski F, Yates M, Smith EG, Magee JG. Antibiotic resistant tuberculosis in the United Kingdom 1993-1999. Thorax. 2002;57:477–482
  18. Conaty SJ, Hayward AC, Story A, Glynn JR, Drobniewski FA, Watson JM. Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance. Epidemiol Infect. 2004;132:1099–1108
  19. Pritchard AJ, Hayward AC, Monk PN, Neal KR. Risk factors for drug resistant tuberculosis in Leicestershire—poor adherence to treatment remains an important cause of resistance. Epidemiol Infect. 2003;130:481–483
  20. Augustynowicz-Kopec E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M, Swidersk A. Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997. Pneumonol Alergol Pol. 2002;70:193–202
  21. Helbling P, Altpeter E, Raeber PA, Pfyffer GE, Zellweger JP. Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: the central link. Eur Respir J. 2000;16:200–202
  22. Robert J, Trystram D, Truffot-Pernot C, Carbonnelle B, Grosset J. Surveillance of Mycobacterium tuberculosis drug resistance in France, 1995-1997. AZAY Mycobacteria Study Group. Int J Tuberc Lung Dis. 2000;4:665–672
  23. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E. Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region. Russia. Thorax. 2005;60:130–135
  24. Clark CM, Li J, Driver CR, Munsiff SS. Risk factors for drug-resistant tuberculosis among non-US born persons in New York City. Int J Tuberc Lung Dis. 2005;9:964–969
  25. Moniruzzaman A, Elwood RK, Schulzer M, Fitzgerald JM. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia. Int J Tuberc Lung Dis. 2006;10:844–850
  26. Baumann MH, Nolan R, Petrini M, Lee YC, Light RW, Schneider E. Pleural tuberculosis in the United States: incidence and drug resistance. Chest. 2007;131:1125–1132
  27. Phyu S, Lwin T, Ti T, Maung W, Mar WW, Shein SS. Drug-resistant tuberculosis in Yangon, Myanmar. Scand J Infect Dis. 2005;37:846–851
  28. Dhingra VK, Rajpal S, Bhalla P, Yadav A, Jain SK, Hanif M. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients. J Commun Dis. 2003;35:82–89
  29. Paramasivan CN, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan PR. Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Dis. 2002;6:479–484
  30. Santha T, Thomas A, Chandrasekaran V, Selvakumar N, Gopi PG, Subramani R. Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Int J Tuberc Lung Dis. 2006;10:52–57
  31. Cox HS, Orozco JD, Male R, Ruesch-Gerdes S, Falzon D, Small I. Multidrug-resistant tuberculosis in central Asia. Emerg Infect Dis. 2004;10:865–872
  32. Araj GF, Saade M, Itani LY. Nationwide study of drug resistance among acid-fast bacilli positive pulmonary tuberculosis cases in Lebanon. Int J Tuberc Lung Dis. 2006;10:63–67
  33. Wilkinson D, Pillay M, Davies GR, Sturm AW. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics. Trans R Soc Trop Med Hyg. 1996;90:692–695
  34. Githui WA, Juma ES, Van Gorkom J, Kibuga D, Odhianbo J, Drobniewski F. Antituberculosis drug resistance surveillance in Kenya, 1995. Int J Tuberc Lung Dis. 1998;2:499–505
  35. Githui WA, Hawken MP, Juma ES, Godfrey-Faussett P, Swai OB, Kibuga DK. Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya. Int J Tuberc Lung Dis. 2000;4:947–955
  36. Maguire H, Dale JW, McHugh TD, Butcher PD, Gillespie SH, Costetsos A. Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax. 2002;57:617–622
  37. Ruddy MC, Davies AP, Yates MD, Yates S, Balasegaram S, Drabu Y. Outbreak of isoniazid resistant tuberculosis in north London. Thorax. 2004;59:279–285

PII: S1201-9712(10)02351-9

doi: 10.1016/j.ijid.2010.02.2247

International Journal of Infectious Diseases
Volume 14, Issue 8 , Pages e717-e722 , August 2010

Article Tools

* Image Usage & Resolution